<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A 72-year-old man has been recently diagnosed with stage 3 squamous cell carcinoma of the oral cavity. After the necessary laboratory workup, concurrent chemoradiation therapy has been planned. Radiation therapy is planned to take place over 7 weeks and he will receive radiation doses daily, MondayFriday, in 2.0 Gy fractions. For concurrent chemotherapy, he will receive intravenous cisplatin at a dosage of 50 mgm2 weekly for 7 weeks. Which of the following best explains the mechanism of action of the antineoplastic drug that the patient will receive?? A: Inhibition of polymerization of tubulin, B: Inhibition of topoisomerase 2, C: Formation of interstrand DNA cross-links, D: Inhibition of topoisomerase 1, E: Free radical-mediated lipid peroxidation,  <response>: This is a question asking about the mechanism of action of cisplatin, which is one of the chemotherapy drugs that will be given to the patient concurrently with radiation therapy for his oral cavity cancer. The key is to understand the mechanism of action of cisplatin specifically.C: Formation of interstrand DNA cross-links 